{"name":"Aer Therapeutics","slug":"aer-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Flexlamose","genericName":"Flexlamose","slug":"flexlamose","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Flexlamose","genericName":"Flexlamose","slug":"flexlamose","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxPTWpXc3VzY3BHVkgtSzBYbE4zc2Rkenc4ZGNYUUZCenVDaEVXdGtYT1pEVWlsWjNmQnplMjNPQjdsaVRhOFdQUDN1eUdUTFQwZUxfOUIwa2NZdFJhZk5lQXZ0ZWpmQzkwY3lLb1dtSnQ2dGlWamJ2NTFhckFreFZNbmtyLXJ2T3lPeG0yMENQOFgxdEhobklMU2VHOVBLYUNyX01iVjRyOVdRZTM2WDB6MncwUk96aUM2TElVRmVDSWFpaTBIU1pXQWJWNUJCcXlsTHBwYmJXdUNDYVFPT09TeVBEaW1HZ0xqMG1MdlgxcF9YTVBRVEIyR3d3anRnTUptcGhsQktRazlzNk9HTmtTV2ZNMGNxOEw3QTR6QThFbDZUazBOekJlRlRmV3Z0b2h4ckdnYnlqMDFvU25rVVdRV1ZTaTFJVl9aZFdzOUEyM3M?oc=5","date":"2026-04-08","type":"pipeline","source":"Barchart.com","summary":"COPD Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma, AstraZene","headline":"COPD Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPbVU3VTdEbmRPWHhKS2hpRmFZRjU5eXFGNXhUdUc5SU51aWR0ZzJXeVpCbDRNaUdSeWN6ZnY2bTB2M0doMUkzUmRKQkFzRi1GRW51cGdXdTlkdmFuTkdsUWtNM3BITXNCZklCdTZ4Z3ZETkZueUNheFhrNGlWN0wyeEpqZWozZnduWmpXcUU3VXllYmlpNTlxT1Vn?oc=5","date":"2025-10-09","type":"pipeline","source":"WSJ","summary":"VCs Pour Capital Into Search for Lung Disease Treatments - WSJ","headline":"VCs Pour Capital Into Search for Lung Disease Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQWnZNS0lnNUg1TnZDRzI2X3Z6WEpva3VURVVNNXFCd0luRENqbXFtNm94SlIxcUZfZE5DRkk5ZGpqeW5oM1NtRnlDck4tNm5IRV9wVVBrelFvTWEwblg2TDJfbG1ZZjNNSU1qaEc2SHlYS05wRlN4R3A0M0lHd2tuZ3kyb1dGeEhWU0JKUFR5N3FxNGx3TzZ0dzRR?oc=5","date":"2025-10-01","type":"pipeline","source":"BioPharma Dive","summary":"A new biotech aims to get RNA drugs into the brain - BioPharma Dive","headline":"A new biotech aims to get RNA drugs into the brain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQdVRuQVpOYl9jN2FTVm11QWNNeE9xZ0taWlRISGk3NnBqbmNZU3JJd0tQVW9VQmVieGxKLThsZHRlMC1YNm1LQ1JUSUJOOXVDbUgxV2h3RkIxZmVXSTVfa2ZLcVE1Zmw0ZHNYcm5hclZNQUN4TkxVYkMyd1BwdGJFdG9CV3NrY1dTV3hoUXNvRjdxUQ?oc=5","date":"2025-10-01","type":"pipeline","source":"Fierce Biotech","summary":"Irish biotech launches with $21M to shuttle RNAi meds to brain - Fierce Biotech","headline":"Irish biotech launches with $21M to shuttle RNAi meds to brain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxPSVpPdTN0NElJUURDVFFpUU16bmdlV0hpRGxhUlVTVjFfYWZWQVRwZVQ3VUh6a1BTSkx1ZzBGbUlKSGlubFRlcEc0eUNWZFlJSHhyZWpLNklTQU5fRGNnMWZ0Zlk3LXRwSU5YV2tYd04zaTlhaWc5U3RIWDFBZGZpNVRzNmJtZEl1dFJrMmpsMjZFMXRVeF9WVUh4UFJib19PQlFJQVBTTGxjOXd3Vmd1OEhOUzBHbG8tSHNCNnNMRlJsVk1tYXIyYWlVME9lYl9FVGdEOXVHTDFMLUhfYTlDcDN3dTFOMk9PeFlXTEdpSWdwNUpFN0NlelI0ZmI?oc=5","date":"2025-10-01","type":"pipeline","source":"GlobeNewswire","summary":"Aerska Launches with $21 Million in Financing to Develop RNAi Medicines for Diseases of the Brain - GlobeNewswire","headline":"Aerska Launches with $21 Million in Financing to Develop RNAi Medicines for Diseases of the Brain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxOQlpabzdseXVpRG1jVGNxOXBnUXM5R3RiZXNrbmRMT2RXWC03cF9NX21wUGFyNXJDWGtZNVByUkRRSkllc2VSbVo4a0tiOFNyU0ZpYk40SThuNFJnU3VMR2FQMWotLWFDSU1tLWdaSnl4VEVmRWc4UHN5QnNoLVVBc0w5cDczNkFaRXlsUUZMYTA2eXR3S1huUXZLOFd2WGZPR1otdUFZZGdaWk96R0lrR21DcDFBVVNCMnJ0WDQ2OWlaYXMyVnQzR1BGbGFEMXYydnQ0ZzE5NGlZQmNrLTM0?oc=5","date":"2023-09-10","type":"pipeline","source":"The Times","summary":"John Fahy’s Aer Therapeutics adding final touches to Ireland’s ‘first blockbuster drug’ - The Times","headline":"John Fahy’s Aer Therapeutics adding final touches to Ireland’s ‘first blockbuster drug’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOTWZJZUxJR0ZfV0ZrazJ6c3JTUmZuRDU4MG5YOTBTbjhYMHJab0VURU1oQmZ6ZGdFLW9rUktZV3JuZVFkYU1NeVFyMzNSQkR2XzB4cjhjeUZIbGRpZXJYR2hZN3huTDFxbTVQc2xwSEVfQktNQnpkWU44S01JVWE5b1Rn?oc=5","date":"2023-04-17","type":"pipeline","source":"labiotech.eu","summary":"Aer Therapeutics raises $36M to tackle lung diseases - labiotech.eu","headline":"Aer Therapeutics raises $36M to tackle lung diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQdk9vZ05SVVVGMkZjTVZmTzI0QjdsS2hmdW5ZbGtkS25hcUpxajJ1SEFWTlIzTDNpaF94YlAtR1lybmgyUzlvU00wdjJFRVNBa1l4STdPMm8xSnlJTHc1SHBFMHFkVjJLVmlEd2xSeDdUR2paUVUtYjR4aTBWYkNMSVJ0UDFZaGpMbEZBNThHMV82TkZxLXRIRVJNTlVYaElIM3dLbW1WcThDZw?oc=5","date":"2023-04-14","type":"pipeline","source":"University College Dublin","summary":"UCD spin-out Aer Therapeutics raises €32.5m in Series A funding - University College Dublin","headline":"UCD spin-out Aer Therapeutics raises €32.5m in Series A funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPczEteFpwenFrN09xVWowU1JsMnFOQ1pGYXdHX050WWtuSnhHeURrbXV2aV9GSkxURHVkRXZyT1hEQzVQRDRQTEcxelM2VzkxRE5KTmJqMHFMdXBEd0pEcE1DN0NGQ3o0YV82Yk04Ui1mMjFWYXJFOU9fcGZ6UUZCU0dIT3hyMmd1NlV6NmY3azR2YjAyUFM0Z3A2YnlXTTlQOTF4eG55S2tyWHNadENpTGNJbWRjeVZVYTRWTnRsQQ?oc=5","date":"2023-04-14","type":"pipeline","source":"The Business Journals","summary":"Raleigh startup raises $36M to advance COPD treatment - The Business Journals","headline":"Raleigh startup raises $36M to advance COPD treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxNSWtFNzBmeVhSalo4SHl1RW1GYlkxQkxrYkZKdS1Tek5lYjV1bTJ1SEp0QjJYWURjaldOMGlOUGpGRlNKRjFmM0NxWE83SUZFZHJJSGNTWEhBVTdDcEw1eExBbFJNYlR5UmwtMDJLMDVjX0dOZExUYV93LWxnbnVUeUVtRFJkeDBra1NzY1F0RVJmMjM3ZWxvTGUta0xTSUh3N1VobXh2QlZWb2pabThYNWxjRnQ4QzlOYlhGbFVVSnB5cGJYR3dnU3VFV2ZFdWhld05yekVUS05xVlFhYTFUQXV4RFEzQ3JwbWN5V1JBemJxTXdnUE5NZHB3ekFBdkxzcUhMYkUxQ2taZ0VWd0hYSV8zRmliSWRlSGtF?oc=5","date":"2023-04-13","type":"pipeline","source":"PR Newswire","summary":"Aer Therapeutics Closes $36 Million Series A to Advance Development of AER-01, an Innovative Mucolytic for the Treatment of Lung Diseases - PR Newswire","headline":"Aer Therapeutics Closes $36 Million Series A to Advance Development of AER-01, an Innovative Mucolytic for the Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNZWhGQVgtRG52c0lLeGpjZldFZXpiM1gzaUhsb0tjR2E5QnVPZ2RrNVFrMUp2UTdyWEdPZGRraTRsM1RLV3Fpa0ZNdW0yRTNITnhXV0VxTEd6OWw4cHAtei03Tm9NRUxRU1JSNDhLRV93Yk1mU0VQamcyMGh5bEh4UEhNZWw0TDhGUkpHbHc5VEZLTVZPYlE?oc=5","date":"2022-12-21","type":"pipeline","source":"BioSpace","summary":"Aerami Therapeutics Appoints Lisa Yañez as Chief Executive Officer - BioSpace","headline":"Aerami Therapeutics Appoints Lisa Yañez as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNZmhyREJ1ZlgxWlJWSnlWUEZweVhWT2taQzhDYVpXc0tKenZJd2hMSGxaOEtqXzVrZWF0V1VEZk5wYXk5SzhyU2FsZWlRWkZHZV9DTjFHR0dELXA5ajlwRlFGajVNdHQyN2NrV0kzejBfSkdBeUNEY01GV3dwQVM1NS1mNzJfeGRPSXFYcFp5TkhHbk5rS2ZVVmxmTUpQQTNET2VhejlRYjYxQTBwdHMzemZYTlR5Nm1FUHRWUQ?oc=5","date":"2022-02-09","type":"pipeline","source":"GSK US","summary":"GSK delivers FY 2021 reported sales of £34 billion, stable at AER, +5% CER; Total EPS 87.6p -24% AER, -13% CER and Adjusted EPS of 113.2p -2% AER, +9% CER - GSK US","headline":"GSK delivers FY 2021 reported sales of £34 billion, stable at AER, +5% CER; Total EPS 87.6p -24% AER, -13% CER and Adjus","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}